中国科学院大学附属肿瘤医院李亚清:教授直播:C-TBNA和EBUS-TBNA在临床中的应用

2021-08-11 MedSci原创 MedSci原创

👉 今晚19:00直播 | 扫码免费报名,0元获取30份最新指南合集

3场精品直播,16大核心知识点,180分钟专业解读!中国科学院大学附属肿瘤医院(浙江省肿瘤医院)李亚清教授在线授课,扫码免费报名。

 

👉嘉宾介绍

图片

_____ 

李 亚 清

现任中国科学院大学附属肿瘤医院(浙江省肿瘤医院)呼吸内科主任医师、博士研究生导师,兼任中华医学会慢性阻塞性肺疾病学组委员,中国医药教育协会介入微创呼吸分会常务委员,海医会呼吸病学专业委员会肺癌学组委员,中国整合医学分会整合呼吸病学专业委员会委员,世界内镜协会呼吸内镜协会委员,浙江省医师协会呼吸医师分会常务委员,浙江省医学会呼吸系病分会委员。

主要专注于呼吸内镜技术的临床应用研究肺癌的早期诊断与治疗、慢阻肺临床与基础研究等。国家自然科学基金评审专家,参与2016年国家精准医学、重大慢性非传染性疾病专项评审。主持国家自然科学基金课题、浙江省科技厅等课题6项。发表论文60篇。获得浙江省科技进步奖1项、浙江省医药卫生科技奖2项。

图片

 

图片

- 免费报名入口 -

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2024397, encodeId=f52b202439ec1, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Oct 22 11:23:12 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723416, encodeId=9ca01e2341601, content=<a href='/topic/show?id=98448285477' target=_blank style='color:#2F92EE;'>#肿瘤医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82854, encryptionId=98448285477, topicName=肿瘤医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb3833453694, createdName=yulin2017, createdTime=Sat Oct 23 10:23:12 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976304, encodeId=0e0319e630450, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Tue Jan 25 23:23:12 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647652, encodeId=2a07164e6520e, content=<a href='/topic/show?id=b08121943e9' target=_blank style='color:#2F92EE;'>#中国科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21943, encryptionId=b08121943e9, topicName=中国科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Mar 20 08:23:12 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930273, encodeId=90f119302e3d9, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 27 03:23:12 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007247, encodeId=1647100e2475d, content=回播怎么看呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20475550490, createdName=朱子洁, createdTime=Thu Aug 12 11:35:28 CST 2021, time=2021-08-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2024397, encodeId=f52b202439ec1, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Oct 22 11:23:12 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723416, encodeId=9ca01e2341601, content=<a href='/topic/show?id=98448285477' target=_blank style='color:#2F92EE;'>#肿瘤医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82854, encryptionId=98448285477, topicName=肿瘤医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb3833453694, createdName=yulin2017, createdTime=Sat Oct 23 10:23:12 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976304, encodeId=0e0319e630450, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Tue Jan 25 23:23:12 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647652, encodeId=2a07164e6520e, content=<a href='/topic/show?id=b08121943e9' target=_blank style='color:#2F92EE;'>#中国科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21943, encryptionId=b08121943e9, topicName=中国科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Mar 20 08:23:12 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930273, encodeId=90f119302e3d9, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 27 03:23:12 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007247, encodeId=1647100e2475d, content=回播怎么看呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20475550490, createdName=朱子洁, createdTime=Thu Aug 12 11:35:28 CST 2021, time=2021-08-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2024397, encodeId=f52b202439ec1, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Oct 22 11:23:12 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723416, encodeId=9ca01e2341601, content=<a href='/topic/show?id=98448285477' target=_blank style='color:#2F92EE;'>#肿瘤医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82854, encryptionId=98448285477, topicName=肿瘤医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb3833453694, createdName=yulin2017, createdTime=Sat Oct 23 10:23:12 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976304, encodeId=0e0319e630450, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Tue Jan 25 23:23:12 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647652, encodeId=2a07164e6520e, content=<a href='/topic/show?id=b08121943e9' target=_blank style='color:#2F92EE;'>#中国科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21943, encryptionId=b08121943e9, topicName=中国科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Mar 20 08:23:12 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930273, encodeId=90f119302e3d9, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 27 03:23:12 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007247, encodeId=1647100e2475d, content=回播怎么看呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20475550490, createdName=朱子洁, createdTime=Thu Aug 12 11:35:28 CST 2021, time=2021-08-12, status=1, ipAttribution=)]
    2022-01-25 qjddjq
  4. [GetPortalCommentsPageByObjectIdResponse(id=2024397, encodeId=f52b202439ec1, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Oct 22 11:23:12 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723416, encodeId=9ca01e2341601, content=<a href='/topic/show?id=98448285477' target=_blank style='color:#2F92EE;'>#肿瘤医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82854, encryptionId=98448285477, topicName=肿瘤医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb3833453694, createdName=yulin2017, createdTime=Sat Oct 23 10:23:12 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976304, encodeId=0e0319e630450, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Tue Jan 25 23:23:12 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647652, encodeId=2a07164e6520e, content=<a href='/topic/show?id=b08121943e9' target=_blank style='color:#2F92EE;'>#中国科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21943, encryptionId=b08121943e9, topicName=中国科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Mar 20 08:23:12 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930273, encodeId=90f119302e3d9, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 27 03:23:12 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007247, encodeId=1647100e2475d, content=回播怎么看呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20475550490, createdName=朱子洁, createdTime=Thu Aug 12 11:35:28 CST 2021, time=2021-08-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2024397, encodeId=f52b202439ec1, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Oct 22 11:23:12 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723416, encodeId=9ca01e2341601, content=<a href='/topic/show?id=98448285477' target=_blank style='color:#2F92EE;'>#肿瘤医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82854, encryptionId=98448285477, topicName=肿瘤医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb3833453694, createdName=yulin2017, createdTime=Sat Oct 23 10:23:12 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976304, encodeId=0e0319e630450, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Tue Jan 25 23:23:12 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647652, encodeId=2a07164e6520e, content=<a href='/topic/show?id=b08121943e9' target=_blank style='color:#2F92EE;'>#中国科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21943, encryptionId=b08121943e9, topicName=中国科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Mar 20 08:23:12 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930273, encodeId=90f119302e3d9, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 27 03:23:12 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007247, encodeId=1647100e2475d, content=回播怎么看呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20475550490, createdName=朱子洁, createdTime=Thu Aug 12 11:35:28 CST 2021, time=2021-08-12, status=1, ipAttribution=)]
    2021-12-27 cy0324
  6. [GetPortalCommentsPageByObjectIdResponse(id=2024397, encodeId=f52b202439ec1, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Oct 22 11:23:12 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723416, encodeId=9ca01e2341601, content=<a href='/topic/show?id=98448285477' target=_blank style='color:#2F92EE;'>#肿瘤医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82854, encryptionId=98448285477, topicName=肿瘤医院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb3833453694, createdName=yulin2017, createdTime=Sat Oct 23 10:23:12 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976304, encodeId=0e0319e630450, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Tue Jan 25 23:23:12 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1647652, encodeId=2a07164e6520e, content=<a href='/topic/show?id=b08121943e9' target=_blank style='color:#2F92EE;'>#中国科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21943, encryptionId=b08121943e9, topicName=中国科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Mar 20 08:23:12 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930273, encodeId=90f119302e3d9, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 27 03:23:12 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007247, encodeId=1647100e2475d, content=回播怎么看呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20475550490, createdName=朱子洁, createdTime=Thu Aug 12 11:35:28 CST 2021, time=2021-08-12, status=1, ipAttribution=)]
    2021-08-12 朱子洁

    回播怎么看呢

    0

相关资讯

恶性中心气道狭窄经支气管镜介入诊疗专家共识

恶性中心气道狭窄是指气管、隆突、左右主支气管及中间段支气管因原发或转移的恶性肿瘤引起的气道狭窄,可导致患者在临床上出现不同程度的呼吸困难或窒息死亡。随着介入呼吸病学技术的快速发展,经呼吸内镜介入已成为恶性中心气道狭窄诊疗的主要手段之一。但目前国内各家单位呼吸介入技术诊疗水平参差不齐,治疗方法亦不统一,治疗效果也存在较大差距,有些甚至导致严重并发症发生。国内恶性中心气道狭窄的介入治疗技术亟需规范化,

Medicine:ICU患者行支气管镜检查,应用右美托咪定还是咪达唑仑?

本研究旨在探讨对需要接受纤维支气管镜检查的重症监护室(ICU)患者来说,右美托咪啶和咪达唑仑的镇静效果有何不同。

Chest:肺部结节三种引导性支气管镜检查的随机比较研究

在尸体模型中与现有技术相比,使用RB明显提高了定位和成功穿刺小型PPNs的能力。这项研究证明RB可以精确到达、定位和穿刺肺周围小结节的潜力。

经过2次支气管镜和经皮肺穿,这个病例终于水落石出!

老张,男,63岁,2月余前无明显原因开始出现咳嗽、咳痰,伴痰中带血,色鲜红,量少。起初伴有发热,体温最高39℃。有时盗汗。无畏寒、寒战,无胸痛、胸闷、气促等。

Chest:超声内镜在肺癌肿瘤辅助疗法后纵膈再分期中的作用

超声内镜检查在肺癌的纵膈再分期中是安全的,并具有高度特异性。

Chest:肺癌分期和诊断的质量差距和有效性比较

按照指南首先进行纵隔采样与检查次数和并发症较少相关。